Lipistop 10 mg (Atorvastatin Calcium Trihydrate)

Adult dose

The recommended starting dose for the treatment of hyperlipidemia is 10 mg of atorvastatin once daily; for patients needing more LDL cholesterol reduction, it can be initiated at 20 mg or 40 mg once daily. The dosage range is 10 to 80 mg once daily. The initial and maintenance doses should be individualized based on treatment goals and patient response, and lipid levels should be analyzed within 2 to 4 weeks after treatment initiation to adjust the dosage accordingly.

Child dose

The recommended starting dose for pediatric patients (10 to 17 years) with heterozygous familial hypercholesterolemia is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage may be adjusted according to treatment goals and should be evaluated at intervals of at least 4 weeks.

This medication may cause adverse effects on muscles, so if there are severe muscle pain or weakness, or significant increases in creatine kinase levels, the medication should be discontinued immediately and a doctor should be consulted. Patients with liver function problems or elevated liver enzymes should not use this medication, and liver health should be regularly monitored. Pregnant women or women who may become pregnant, and breastfeeding mothers should not take this medication, and women of childbearing age should use appropriate contraception while taking it. Children, especially those under 10 years old, should not take this medication, and the safety and efficacy in pediatric patients aged 10 to 17 have not been sufficiently studied. Patients with a history of alcohol abuse or liver disease should use this medication cautiously, and the elderly or patients with impaired kidney function are at higher risk for muscle-related side effects and should be careful. Due to many drug interactions, especially with certain antibiotics, antifungals, antivirals, or specific lipid-lowering agents, it is essential to inform a doctor or pharmacist when taking them, as dosage adjustments may be necessary. If symptoms such as muscle pain, fatigue, or fever occur during treatment, medical personnel should be notified immediately, and regular blood tests to monitor liver function and muscle status are essential. There is no specific antidote for overdose, so symptomatic treatment should be provided and liver function and muscle enzyme levels should be carefully monitored. This medication should be kept out of reach of children and should not be removed from its original container to another container. If severe allergic reactions such as skin rash, hives, fever, or mucosal damage occur, the medication should be discontinued immediately, and emergency treatment sought. As there may be an increased risk of diabetes, blood sugar levels should be monitored regularly and appropriate treatment should be sought if necessary.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, dyspnea or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of the skin or eyes), severe malaise, sudden and severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination changes

Mild side effects

• Weakness
• fatigue
• chest pain
• peripheral edema
• tiredness
• fever
• pharyngitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain room temperature between 1 degree and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

30 tablets (10 tablets x 3)/Alu-Alu, 100 tablets/bottle